• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

0.9% NaCl 之争:站不住脚的,能否站得住脚?

The case for 0.9% NaCl: is the undefendable, defensible?

机构信息

Department of Intensive Care, Erasmus MC University Hospital Rotterdam, Rotterdam, The Netherlands.

出版信息

Kidney Int. 2014 Dec;86(6):1087-95. doi: 10.1038/ki.2014.193. Epub 2014 Jul 9.

DOI:10.1038/ki.2014.193
PMID:25007167
Abstract

Although 0.9% NaCl solution is by far the most-used fluid for fluid therapy in resuscitation, it is difficult to find a paper advocating its use over other types of crystalloid solutions. Literature on the deleterious effects of 0.9% NaCl has accumulated over the last decade, but critical appraisal of alternative crystalloid solutions is lacking. As such, the literature seems to suggest that 0.9% NaCl should be avoided at all costs, whereas alternative crystalloid solutions can be used without scrutiny. The basis of this negative evaluation of 0.9% NaCl is almost exclusively its effect on acid-base homeostasis, whereas the potentially deleterious effects present in other types of crystalloids are neglected. We have the challenging task of defending the use of 0.9% NaCl and reviewing its positive attributes, while an accompanying paper will argue against the use of 0.9% NaCl. It is challenging because of the large amount of literature, including our own, showing adverse effects of 0.9% NaCl. We will discuss why 0.9% NaCl solution is the most frequently used resuscitation fluid. Although it has some deleterious effects, all fluids share common features of concern. As such the emphasis on fluid resuscitation should be on volume rather than on composition and should be accompanied by a physiological assessment of the impact of fluids. In this paper, we hope to discuss the context within which fluids, specifically 0.9% NaCl, can be given in a safe and effective manner.

摘要

尽管 0.9%氯化钠溶液迄今为止是复苏中最常用的液体疗法流体,但很难找到一篇提倡将其用于其他类型晶体溶液的论文。在过去十年中,关于 0.9%氯化钠溶液有害影响的文献已经积累起来,但对替代晶体溶液的批判性评价却缺乏。因此,文献似乎表明,应该不惜一切代价避免使用 0.9%氯化钠溶液,而可以不加审查地使用替代晶体溶液。对 0.9%氯化钠溶液的这种负面评价的基础几乎完全是其对酸碱平衡的影响,而其他类型晶体溶液中存在的潜在有害影响则被忽视了。我们面临着一项艰巨的任务,既要为 0.9%氯化钠溶液的使用辩护并审查其积极属性,同时还要有一篇伴随的论文来反对使用 0.9%氯化钠溶液。之所以具有挑战性,是因为有大量文献,包括我们自己的文献,都表明 0.9%氯化钠溶液有不良影响。我们将讨论为什么 0.9%氯化钠溶液是最常使用的复苏液。尽管它有一些有害影响,但所有液体都有共同的关注点。因此,液体复苏的重点应该是容量而不是成分,并且应该伴随着对液体影响的生理评估。在本文中,我们希望讨论在何种情况下可以安全有效地给予液体,特别是 0.9%氯化钠溶液。

相似文献

1
The case for 0.9% NaCl: is the undefendable, defensible?0.9% NaCl 之争:站不住脚的,能否站得住脚?
Kidney Int. 2014 Dec;86(6):1087-95. doi: 10.1038/ki.2014.193. Epub 2014 Jul 9.
2
Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent 'pre-renal' acute kidney injury?: con.富含氯化物的晶体液应继续作为液体复苏的主要手段以预防“肾前性”急性肾损伤吗?:反对观点
Kidney Int. 2014 Dec;86(6):1096-105. doi: 10.1038/ki.2014.105. Epub 2014 Apr 9.
3
Does saline resuscitation affect mechanisms of coagulopathy in critically ill trauma patients? An exploratory analysis.生理盐水复苏对重症创伤患者凝血功能障碍机制有何影响?一项探索性分析。
Blood Coagul Fibrinolysis. 2015 Apr;26(3):250-4. doi: 10.1097/MBC.0000000000000154.
4
Saline Is Not the First Choice for Crystalloid Resuscitation Fluids.生理盐水并非晶体复苏液的首选。
Crit Care Med. 2016 Aug;44(8):1541-4. doi: 10.1097/CCM.0000000000001941.
5
Association between Initial Fluid Choice and Subsequent In-hospital Mortality during the Resuscitation of Adults with Septic Shock.在成人脓毒性休克复苏期间,初始液体选择与随后院内死亡率之间的关联。
Anesthesiology. 2015 Dec;123(6):1385-93. doi: 10.1097/ALN.0000000000000861.
6
Intravenous solutions in the care of patients with volume depletion and electrolyte abnormalities.静脉输液溶液在容量不足和电解质异常患者中的应用。
Am J Kidney Dis. 2015 Jul;66(1):147-53. doi: 10.1053/j.ajkd.2015.01.031. Epub 2015 Apr 24.
7
Intravenous fluids: balancing solutions.静脉输液:平衡溶液
J Nephrol. 2017 Aug;30(4):485-492. doi: 10.1007/s40620-016-0363-9. Epub 2016 Nov 29.
8
Balanced crystalloids for septic shock resuscitation.用于感染性休克复苏的平衡晶体液
Rev Bras Ter Intensiva. 2016 Oct-Dec;28(4):463-471. doi: 10.5935/0103-507X.20160079.
9
Fluid Resuscitation: Principles of Therapy and "Kidney Safe" Considerations.液体复苏:治疗原则和“肾脏安全”的考虑因素。
Adv Chronic Kidney Dis. 2017 Jul;24(4):205-212. doi: 10.1053/j.ackd.2017.05.002.
10
Fluid resuscitation in the trauma patient.创伤患者的液体复苏
J Trauma Nurs. 2008 Jul-Sep;15(3):149-57. doi: 10.1097/01.JTN.0000337160.46582.d7.

引用本文的文献

1
A balancing act: drifting away from the reflexive use of "ab"normal saline.一种平衡的行为:减少对“ab”正常生理盐水的反射性使用。
Pediatr Nephrol. 2024 Aug;39(8):2325-2335. doi: 10.1007/s00467-023-06271-8. Epub 2024 Jan 18.
2
Normal saline: Past, present, and future.生理盐水:过去、现在和未来。
Sci Prog. 2023 Apr-Jun;106(2):368504231168821. doi: 10.1177/00368504231168821.
3
Photodynamic Inactivation of in Blood Plasma and Whole Blood.血浆和全血中 的光动力灭活
Antibiotics (Basel). 2019 Nov 13;8(4):221. doi: 10.3390/antibiotics8040221.
4
Acute Kidney Injury and Fluid Resuscitation in Septic Patients: Are We Protecting the Kidney?脓毒症患者的急性肾损伤与液体复苏:我们在保护肾脏吗?
Nephron. 2019;143(3):170-173. doi: 10.1159/000501748. Epub 2019 Aug 8.
5
Comparison of Normal Saline, Ringer's Lactate, and Sodium Bicarbonate for Prevention of Contrast-induced Nephropathy in Patients with Coronary Angiography: A Randomized Double-blind Clinical Trial.生理盐水、乳酸林格氏液和碳酸氢钠预防冠状动脉造影患者造影剂肾病的比较:一项随机双盲临床试验
Indian J Nephrol. 2019 Jan-Feb;29(1):22-27. doi: 10.4103/ijn.IJN_48_17.
6
"I don't get no respect": the role of chloride in acute kidney injury.“我得不到尊重”:氯离子在急性肾损伤中的作用。
Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F587-F605. doi: 10.1152/ajprenal.00130.2018. Epub 2018 Dec 12.
7
Strategies for Intravenous Fluid Resuscitation in Trauma Patients.创伤患者静脉液体复苏策略
World J Surg. 2017 May;41(5):1170-1183. doi: 10.1007/s00268-016-3865-7.
8
Normal saline as resuscitation fluid in critically ill patients: not dead yet!生理盐水作为危重症患者的复苏液体:尚未过时!
Ann Intensive Care. 2016 Dec;6(1):120. doi: 10.1186/s13613-016-0227-4. Epub 2016 Dec 28.
9
Plasma-Lyte 148: A clinical review.聚磺基乙酸钠注射液148:临床综述。
World J Crit Care Med. 2016 Nov 4;5(4):235-250. doi: 10.5492/wjccm.v5.i4.235.
10
Choice of crystalloids in sepsis: a conundrum waiting to be solved.脓毒症中晶体液的选择:一个亟待解决的难题。
Ann Transl Med. 2016 Mar;4(6):121. doi: 10.21037/atm.2016.02.09.